Peter Cayan, senior director for Intalere’s Nutrition and Environmental Specialist team, is joined by Dr. Tracy Smith, senior clinical manager for Abbott Nutrition to discuss nutrition in the changing healthcare landscape.

**Please view these slides as you listen to the podcast: https://members.amerinet-gpo.com/Portals/3/Marketing/misc/ENFit_Slides.pdf

-----Provided by Thomas Hancock, Founder and Executive Director, The Global Enteral Device Supplier Association (GEDSA)

On successful completion of this activity, you should be able to: Outline the background of Tubing Misconnections issue; Explain why new small bore connector design standards are needed; Describe features of the new enteral connector standards and their safety implications; Plan the timeline needed to effectively implement and transition new connector design; State supply chain efforts needed to increase awareness among end user.

Intalere welcomes to the discussion Mike Hodgson, Vice President of Healthcare and Corporate Partnerships at Career Step. Mike has over 25 years of proven success helping clients achieve desired outcomes in the healthcare industry. Throughout his career, Mike has been responsible for driving positive change for clients, as well as the organizations for which he has served in sales, operations and finance roles. Mike is focused on improving productivity and enhancing operations through strategic planning and a commitment to finding positive solutions that meet the business objectives of his customers. Our topic for this episode will be focused on the transition to the ICD-10 Coding system. More specifically, we will be discussing the educational and training needs associated with this transition and where your facility should be in the planning phase. We will also we talking about how to accomplish adequate training without reducing productive work time and other concerns and challenges that may be faced during this transitional period.

Intalere welcomes Brian Williamson, Pharm.D., President and Chief Executive Officer, JCB Laboratories. Dr. Williamson devotes his time and energy to compounding and supplying sterile products to ambulatory surgery centers and hospitals and working with consultant pharmacists from around the country to help them keep their clients compliant with sterile regulations. In this session Dr. Williamson will address the drug shortage issue and why it has become a common problem for hospital pharmacies. He will review the drugs which are the most problematic for hospital pharmacies to acquire at this time. Dr. Williamson will discuss the unavailability of chemotherapeutic drugs and the evolution of the Gray Market. The term pedigree drug is defined. In conclusion, Dr. Williamson will offer recommendations on managing drug shortage issues.

Intalere welcomes Brian Williamson, Pharm.D., President and Chief Executive Officer, JCB Laboratories. Dr. Williamson devotes his time and energy to compounding and supplying sterile products to ambulatory surgery centers and hospitals and working with consultant pharmacists from around the country to help them keep their clients compliant with sterile regulations. We will discuss the process of sterile compounding, USP 797 and how it relates to actual standards and operational procedures for Sterile Compounding. Dr. Williamson will discuss the role of the FDA or the State Board of Pharmacy in the oversight of Sterile Compounding and inspections of Compounding Pharmacies. The training/educational requirements for pharmacy techs and others who compound and distribute these medications is outlined. Lately, Dr. Williamson will recommend questions to ask when considering outsourcing products from a compounding pharmacy.

Intalere’s Quality and Patient Safety Department welcomes Yvette Gaughan, MS, RD, LDN from Nestlé Health Science. With an estimated 24 million cases in the U.S. alone, Dysphagia is a common condition. However, if left untreated, dysphagia can often lead to malnutrition and dehydration and if undiagnosed, can lead to aspiration pneumonia or even chronic lung disease. Our discussion today will include a brief overview of what dysphagia is, the clinical presentation of dysphagia and the signs and symptoms it presents. We hope this information will help increase your knowledge on some of the key aspects related to the management of dysphagia.

If you are interested in learning more about the EAT 10 Screening tool or the wide variety of dysphagia products available through Nestlé, please contact your Nestlé Health Science representative or visit us at www.nestlehealthscience.us

"This presentation has been prepared and sponsored by Nestlé HealthCare Nutrition, Inc. The material herein is intended for healthcare professionals and educational purposes only and should not be construed as a substitute for medical advice. Reproduction or distribution of these materials is prohibited. Copyright 2012 Nestlé. All rights reserved."

Intalere welcomes Attorney William H. Maruca, Partner from the prestigious Fox Rothschild firm here in Pittsburgh. Mr. Maruca will discuss the 2012 U.S. Supreme Court Ruling on the Patient Protection and Affordable Care Act. On June 28th, 2012, by a narrow 5-4 decision, the United States Supreme Court ruled largely in favor of upholding nearly all provisions of the Affordable Care Act. Mr. Maruca will provide an overview of what was at issue and why the court’s ruling was so consequential. He will explain the court’s ruling on the constitutionality of the "individual mandate" provision of the ACA and why Chief Justice Roberts' opinion was so significant to the outcome. Attorney Maruca will address the implications and penalties for those who choose not to purchase health insurance, the intent of the "Medicaid expansion", financial implications for those states giving consideration to a refusal to expand their Medicaid programs under PPACA, and some of the open questions in the wake of the decision.

Intalere welcomes Attorney William H. Maruca, Partner from the prestigious Fox Rothschild firm in Pittsburgh. Mr. Maruca will discuss the changes providers can expect to experience in the near future as a result of Supreme Court decision to uphold the Affordable Care Act. He will describe the purpose and initiatives on the Center for Medicare and Medicaid Innovation (CMMI), ACA provisions that will resonate positively from a consumer standpoint and how employers will be affected in terms of health benefit provisions to their employees. Attorney Maruca will address the ACA's expansion in Medicaid coverage and its impact on the states. Bill will explain how hospitals in states choosing not to implement the expansion will be affected. Bill concludes with describing what is next for state "insurance exchanges" and some of the other ACA-related changes and challenges we might anticipate over the next few years.

Intalere welcomes Steven M Riddle, BS Pharm, BCPS, FASHP, Vice President of Clinical Affairs for Pharmacy OneSource (part of Wolters Kluwer Health); a healthcare information technology company that provides web-based solutions that improve quality of care and financial performance for hospitals. Mr. Riddle will review the drivers of readmissions reduction, transitions in the continuum of care, and helpful data for organizations beginning to implement improvement strategies around reducing avoidable readmission. Mr. Riddle will review evidence-based strategies and best practices for reducing readmissions including studies and initiatives involving discharge advocates, the pharmacist’s role, care transition programs, a focus on managing a specific high risk population for readmission, and medication management/counseling processes. Lastly, Steven will offer recommendations to pharmacists as they address the readmissions issue at their organizations.